A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
(Q45250754)
scientific article published on 30 May 2010
scientific article published on 30 May 2010
Language:
Current Data About
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
other details
| description | scientific article published on 30 May 2010 |
External Links
| (P356) |
10.1007/S00345-010-0570-2
|
| (P698) |
20512580
|
| (P6179) |
1037814340
|